Online Health Assessment to Support Comprehensive Care
|ClinicalTrials.gov Identifier: NCT02122302|
Recruitment Status : Withdrawn (Study was terminated due to unsuccessful accrual.)
First Posted : April 24, 2014
Last Update Posted : December 13, 2017
|Condition or disease||Intervention/treatment||Phase|
|Chronic Pancreatitis||Device: CarePrep Online Health Assessment||Not Applicable|
The following aims will be addressed:
Aim 1: Refine and extend CarePrep content for targeted disorders.
Working with experts at our sites, the study team will review CarePrep content in association with current literature and established instruments. Applying this data, a comprehensive pain assessment will be developed and content to target chronic pancreatic pain (CPP) will be prioritized. During Phase 1 of the study, the system will be deployed, patient testing begun, and feedback gathered to guide refinement. Patients will be asked to complete their online CarePrep assessment before their scheduled clinic visit; the report will be delivered to their attending physician prior to the clinic encounter. Patients who are unable to complete their assessment at home will have access to electronic tablets which will be provided in clinic.
Aim 2: Test with patients, gather feedback, and conduct cognitive and structured interviews to assess validity.
Research staff will conduct individual patient interviews to assess CarePrep validity, via the following ways: Cognitive interviews probing for CarePrep comprehension and ease of use, as well as measuring patients' rationale for selecting their online responses; structured interviews that will include a block of standardized questions that mirror the online CarePrep assessment (patients' interview responses will be compared to data from their online session to assess the sensitivity of CarePrep screening questions); and patients' ratings of CarePrep's accuracy will be collected to improve and validate system design.
Aim 3: Assess feasibility.
In Phase II of the study, physician and patient self-reports will be used to assess feasibility and utility. The objective of this phase is to deliver a system that supports a comprehensive health assessment and facilitates physician-patient communication so that physicians will adopt the system for routine care.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Online Health Assessment to Support Comprehensive Care|
|Study Start Date :||May 2014|
|Actual Primary Completion Date :||May 31, 2016|
|Actual Study Completion Date :||May 31, 2016|
|Experimental: Web-based health assessment||
Device: CarePrep Online Health Assessment
Patients can utilize a web-based self-assessment system to answer questions that address medical, psychological, social, behavioral, and quality-of-life issues that are relevant to pancreatic disease. Patients can enter and track their symptoms over the Internet from home or clinic. The system is also designed to gather clues to identify neuropathic pain, which occurs when the nervous system fails to properly regulate pain signals.
Other Name: Online CarePrep Assessment (OCA)
- Physician and patient evaluation of validity and feasibility of online patient self-assessment system to support integrated gastrointestinal and biopsychosocial care [ Time Frame: One year ]
Feedback via cognitive and structured interviews will assess validity: Cognitive interviews will probe for CarePrep comprehension and ease of use and will measure patients' rationale for selecting their online responses; structured interviews will include a block of standardized questions mirroring the online CarePrep assessment; patients' interview responses will be compared to data from their online session to assess the sensitivity of CarePrep screening questions; patients' ratings of CarePrep's accuracy will be collected to improve and validate system design; and experts and clinicians will review relevant sections of the CarePrep report for accuracy in order to address the utility and accuracy of reported data..
Physician and patient self-reports will assess feasibility and utility: After the refinement and validation phases have been completed, patients and clinicians will score the usefulness of Careprep in routine clinic use via brief self-reports.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02122302
|United States, California|
|Cedars-Sinai Medical Center|
|Los Angeles, California, United States, 90048|
|Principal Investigator:||Simon K Lo, M.D.||Cedars-Sinai Medical Center|
|Principal Investigator:||Stephen J Pandol, M.D.||Cedars-Sinai Medical Center|